HIV/HBV co-infection and rate of antiretroviral treatment change after highly active antiretroviral treatment initiation in a cohort of HIV-infected patients in Greece.

about

Seroprevalence of hepatitis C, hepatitis B virus and syphilis in HIV-1 infected patients in Shandong, China.

P2860

Q45354508-82D2100B-5219-4521-8CE3-3AA9ACAA47ED

P2860

HIV/HBV co-infection and rate of antiretroviral treatment change after highly active antiretroviral treatment initiation in a cohort of HIV-infected patients in Greece.

Item

http://www.wikidata.org/entity/Q38441522

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

HIV/HBV co-infection and rate ...... V-infected patients in Greece.

@en

type

Item

label

HIV/HBV co-infection and rate ...... V-infected patients in Greece.

@en

prefLabel

HIV/HBV co-infection and rate ...... V-infected patients in Greece.

@en

P1476

HIV/HBV co-infection and rate ...... V-infected patients in Greece.

@en

P2093

A Hatzakis

http://www.w3.org/2001/XMLSchema#string

D Paraskevis

http://www.w3.org/2001/XMLSchema#string

E Hatzitheodorou

http://www.w3.org/2001/XMLSchema#string

V Kalapothaki

http://www.w3.org/2001/XMLSchema#string

V Sypsa

http://www.w3.org/2001/XMLSchema#string

X Zavitsanos

http://www.w3.org/2001/XMLSchema#string

Z Moschidis

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV observational database.

Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial.

Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group

Ways of measuring rates of recurrent events.

Future directions in the treatment of HIV-HBV coinfection.

Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.

The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection.

Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.

P304

702-707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1258/IJSA.2010.010112

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Georgios K. Nikolopoulos

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21139149

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

HIV/HBV co-infection and rate of antiretroviral treatment change after highly active antiretroviral treatment initiation in a cohort of HIV-infected patients in Greece.

about

P2860

P2860

HIV/HBV co-infection and rate of antiretroviral treatment change after highly active antiretroviral treatment initiation in a cohort of HIV-infected patients in Greece.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921